Original news and analysis on international IP policy
Global public health experts in charge of exploring ways to finance R&D on diseases endemic in developing countries last week provided a preliminary summary of assessments on proposals provided by various stakeholders. They also made recommendations to establish global mechanisms, including a binding global instrument for R&D and innovation for health.
The European Commission today presented its annual report on customs activities related to intellectual property rights (IPR) infringing goods, finding sharp increases in some areas and leading to calls for new enforcement measures.
The World Health Organization will be entering a new phase of its global action plan for influenza vaccines, a WHO representative told reporters today. The goals of the first phase of the programme should be furthered but with more attention given to the local health and policy environment, WHO said.
The Medicines Patent Pool and pharmaceutical company Gilead Sciences today announced a breakthrough licence agreement to allow for the production of key HIV medicines at lower cost and in an easier-to-use formulation, making them more accessible to developing countries. The agreement also opens up the use of treatments for Hepatitis B for the first time.
A diverse team of global experts on public health research and development will meet this week behind closed doors to analyse proposals for ways to fund R&D on diseases afflicting poor populations – and for who should coordinate such global efforts.
The US House of Representatives this evening passed HR 1249 – the closest action patent reform has come to being enacted into law in the past 10 years. But there were some changes made to the bill.
In remarks that have raised questions among libraries and the information technology industry, World Intellectual Property Organization Director General Francis last week told a copyright industry gathering that it is time to move away from a “negative” agenda of limitations and exceptions to copyright. It may also be a time for more private-sector involvement in international policymaking, he said.
The Drugs for Neglected Diseases initiative (DNDi) signed an agreement with pharmaceutical manufacturer Sanofi on 30 May for a three-year research project on nine neglected tropical diseases that will come with intellectual property rights on research results for both sides, according to a press release from the international organisation in Switzerland.
Improving access to medicines in developing countries through local pharmaceutical production is at the centre of a project involving several institutional actors working on health and trade. Technology transfer is key to local production, but some prerequisites like a favourable policy environment and the ability of developing countries to use technology transfer are essential to encourage local production, according to panellists at a recent event.
It was a mixed message going out from the eG8 Forum - the first “Internet G8 meeting“ - that ended in Paris this week and passed its results to the heads of state of the Group of 8 most industrialised countries meeting now in Deauville, France.